Allen Mooney & Barnes Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Allen Mooney & Barnes Investment Advisors's PFE Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $88.5K and leaving 22,543 shares worth $543K. The position accounts for 0.08% of the portfolio, ranked #93.
Allen Mooney & Barnes Investment Advisors first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $11.6M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors held 22,543 shares of Pfizer worth $543K as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors sold 3,385 Pfizer shares in Q2 2026, an estimated $88.5K.
- Pfizer made up 0.08% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #93 holding.
- Allen Mooney & Barnes Investment Advisors first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
- Allen Mooney & Barnes Investment Advisors's Pfizer position peaked at $11.6M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.